U.S. senator reveals results of opioid inquiry into Insys

BOSTON (Reuters) - Insys Therapeutics Inc sought to manipulate the process to gain insurance payment approval for an opioid cancer pain drug called Subsys even if for inappropriate uses, according to a U.S. Senate report related to the national opioid addiction crisis released on Wednesday.

from Reuters: U.S. http://ift.tt/2wGWrWY